Article Link: FDA Approves Toujeo (insulin glargine) Max SoloStar

BRIDGEWATER, N.J., March 27, 2018 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) approved Sanofi’s Toujeo (insulin glargine 300 Units/mL) Max SoloStar, the highest capacity long-acting insulin pen that will be available on the…

Source: FDA New Drug Approvals